Hepatocyte Transplantation Activates Hepatic Stellate Cells With Beneficial Modulation of Cell Engraftment in the Rat *
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 42 (5) , 1072-1081
- https://doi.org/10.1002/hep.20889
Abstract
: We investigated whether transplanted hepatocytes interact with hepatic stellate cells, as cell–cell interactions could modulate their engraftment in the liver. We transplanted Fischer 344 rat hepatocytes into syngeneic dipeptidyl peptidase IV–deficient rats. Activation of hepatic stellate cells was analyzed by changes in gene expression, including desmin and α-smooth muscle actin, matrix proteases and their inhibitors, growth factors, and other stellate cell-associated genes with histological methods or polymerase chain reaction. Furthermore, the potential role of hepatic ischemia, Kupffer cells, and cytokine release in hepatic stellate cell activation was investigated. Hepatocyte transplantation activated desmin-positive hepatic stellate cells, as well as Kupffer cells, including in proximity with transplanted cells. Inhibition of Kupffer cells by gadolinium chloride, blockade of tumor necrosis factor alpha (TNF-α) activity with etanercept or attenuation of liver ischemia with nitroglycerin did not decrease this hepatic stellate cell perturbation. After cell transplantation, soluble signals capable of activating hepatic stellate cells were rapidly induced, along with early upregulated expression of matrix metalloproteinases-2, -3, -9, -13, -14, and their inhibitors. Moreover, prior depletion of activated hepatic stellate cells with gliotoxin decreased transplanted cell engraftment. In conclusion , cell transplantation activated hepatic stellate cells, which, in turn, contributed to transplanted cell engraftment in the liver. Manipulation of hepatic stellate cells might provide new strategies to improve liver repopulation after enhanced transplanted cell engraftment. Supplementary material for this article can be found on the H epatology website ( http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html ). (Hepatology 2005;42:1072–1081.)Keywords
This publication has 37 references indexed in Scilit:
- Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liverHepatology, 2002
- Interactions between Hepatic Stellate Cells and the Immune SystemSeminars in Liver Disease, 2001
- Rat hepatic stellate cells contribute to the acute-phase response with increased expression of α1(I) and α1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAsHepatology, 2001
- Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cellsHepatology, 2000
- Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1Journal of Hepatology, 1999
- Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healingOncogene, 1998
- Effect of tumour necrosis factor-α on proliferation, activation and protein synthesis of rat hepatic stellate cellsJournal of Hepatology, 1997
- Fibroblast growth factor 2 and transforming growth factor β1 interactions in human liver myofibroblastsGastroenterology, 1995
- Mitogenic effect of transforming growth factor-β1 on human ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factorHepatology, 1993
- Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cellsHepatology, 1992